ORIGINAL ARTICLE |
|
Year : 2014 | Volume
: 55
| Issue : 6 | Page : 504-507 |
|
Crystalluria in HIV/AIDS patients on highly active anti-retroviral therapy in the Kumasi metropolis; a cross sectional study
Richard K. D. Ephraim1, Ruth C Brenyah2, Richmond Osei3, Bright D Bossipe1, Prince Adoba1, Derick N. M. Osakunor4, Hope Agbodzakey1
1 Department of Laboratory Technology, Medical Laboratory Division, University of Cape Coast, Cape Coast, Ghana 2 Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana 3 Department of Medical Laboratory Technology, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana 4 Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
Correspondence Address:
Richard K. D. Ephraim Department of Laboratory Technology, Medical Laboratory Division, University of Cape Coast, Cape Coast Ghana
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0300-1652.144709
|
|
Background: Crystalluria is associated with some highly active anti-retroviral therapies (HAART's) used in the management of HIV/AIDS. Aims: This study used light microscopy to establish the prevalence of crystalluria among HIV/AIDS patients on HAART and identified the routine crystals present in their urine. Materials and Methods: In this simple randomised cross-sectional study, 200 HIV/AIDS participants, comprising 150 on HAART and 50 HAART-naοve were recruited from the HIV clinic at the Komfo Anokye Teaching Hospital (KATH). Urine and blood samples were collected, for urinalysis and the determination of the CD4 count, respectively. A well-structured pre-tested questionnaire was used to obtain socio-demographic data and clinical history of the participants. Results: The prevalence of crystalluria was higher among HIV-infected persons on HAART than those not on HAART (6.7% vs 4%; P = 0.733). Calcium oxalate and triple phosphate crystals were the crystal types present in their urine (3.5% and 2.5%, respectively) and was present only in HIV subjects on first line of treatment (without protease inhibitors). Participants aged between 40-50 years and those with hypersthenuria and acidic urine had the highest amount of crystalluria (41.6%, 83.3%, and 58.3%, respectively). Conclusion: HAART is associated with crystalluria in HIV patients. Light microscopy will be of disgnostic value in resource limited settings. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|